A Spatial Biology Approach For Biomarker Discovery and Validation in Immuno-Oncology
In this presentation, from the 2021 Spatial Biology Europe Congress, Gavin Gordon, Ph.D., Vice President, Clinical Market Development from Akoya Biosciences describes evolving biomarker strategies in immuno-oncology and how multiplexed immunofluorescence has been associated with improved predictive performance. Dr Sebastian Marwitz, ARCN Principal Investigator, Pathology from Research Center Borstel - Leibniz Lung Center, describes how multiplexed IHC has been used for the spatial profiling in lung disease in hypotheses-driven analyses at a cohort level using FFPE patient samples. Learn more : https://www.akoyabio.com Follow Akoya Biosciences: Tweet with us on Twitter: Akoya Biosciences (@AkoyaBio) / Twitter Link with us on Linkedin: Akoya Biosciences, Inc. | LinkedIn
Opal Multiplex and Simulated H&E on The Same Tissue Section
Spatial Biology Speaker Panel
AlphaFold - The Most Useful Thing AI Has Ever Done
6 Tips on Being a Successful Entrepreneur | John Mullins | TED
Quantitative Multiplex Assays for Pan-Cancer Immuno-Oncology | Kathleen Pfaff, PhD | Dana-Farber
Correlation of Multiplex Immunofluorescence with RNA Sequencing | Zhongmin Xiang, PhD | BostonGene
Journal Club | Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
Transformers, the tech behind LLMs | Deep Learning Chapter 5
OPEN Stage Webinar: Biomarker development and validation
How AI Cracked the Protein Folding Code and Won a Nobel Prize
How ASML Makes Chips Faster With Its New $400 Million High NA Machine
Spatial Biology of Tumor Microenvironments for Clinical Biomarker Development and Therapy Prediction
Lighting in Godot for Beginners
The World's Most Important Machine
Data Analysis Solutions
But what is quantum computing? (Grover's Algorithm)
How is Immunotherapy for Liver Cancer Changing the Outlook for Patients?
Pain Physiology | Nociception
